David Mark Steinhaus
Directeur/Membre du Conseil chez EBR SYSTEMS, INC.
Profil
David Mark Steinhaus is currently the Executive Chairman at Enopace Biomedical Ltd.
He is also an Independent Non-Executive Director at EBR Systems, Inc. and a Director at Qardio, Inc. Dr. Steinhaus previously worked as the VP & General Manager-Heart Failure Business at Cardiac Rhythm & Heart Failure.
He holds a doctorate degree from Harvard Medical School and an undergraduate degree from Harvard College.
Postes actifs de David Mark Steinhaus
Sociétés | Poste | Début |
---|---|---|
EBR SYSTEMS, INC. | Directeur/Membre du Conseil | 08/11/2021 |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | Président | - |
Qardio, Inc.
Qardio, Inc. Medical DistributorsDistribution Services Qardio, Inc. engages in the provision of wearable applications including heart monitoring devices to track health. It offers healthcare solutions for patients, doctors, and healthcare providers. The company was founded by Marco Peluso and Rosario Iannella in 2012 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | 10/08/2022 |
Anciens postes connus de David Mark Steinhaus
Sociétés | Poste | Fin |
---|---|---|
Cardiac Rhythm & Heart Failure | Corporate Officer/Principal | - |
Formation de David Mark Steinhaus
Harvard Medical School | Doctorate Degree |
Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
EBR SYSTEMS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | Health Technology |
Qardio, Inc.
Qardio, Inc. Medical DistributorsDistribution Services Qardio, Inc. engages in the provision of wearable applications including heart monitoring devices to track health. It offers healthcare solutions for patients, doctors, and healthcare providers. The company was founded by Marco Peluso and Rosario Iannella in 2012 and is headquartered in San Francisco, CA. | Distribution Services |
Cardiac Rhythm & Heart Failure |